Regencell Bioscience Holdings Ltd
RGC Nasdaq
SEC CIK 1829667
Follow Regencell Bioscience
Weekly email: filings, results
Show the numbers
| Year | Net income |
|---|---|
| FY26 | −$11.7M |
| FY25 | −$3.6M |
| FY24 | −$4.3M |
| FY23 | −$5.9M |
| FY22 | −$7.4M |
| FY21 | - |
| FY20 | −$812.4K |
| FY19 | −$391K |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY26 | - |
| FY25 | −$3.3M |
| FY24 | −$4M |
| FY23 | −$5M |
| FY22 | −$6M |
| FY21 | - |
| FY20 | −$844.4K |
| FY19 | - |